215 related articles for article (PubMed ID: 28433794)
1. Detection of melanoma metastases with PET-Comparison of
Wang Y; Li M; Zhang Y; Zhang F; Liu C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2017 Jul; 50():33-38. PubMed ID: 28433794
[TBL] [Abstract][Full Text] [Related]
2. Imaging malignant melanoma with (18)F-5-FPN.
Feng H; Xia X; Li C; Song Y; Qin C; Liu Q; Zhang Y; Lan X
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):113-122. PubMed ID: 26260649
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Preclinical Evaluation of
Xu X; Yuan L; Yin L; Jiang Y; Gai Y; Liu Q; Wang Y; Zhang Y; Lan X
Mol Pharm; 2017 Nov; 14(11):3896-3905. PubMed ID: 29037039
[TBL] [Abstract][Full Text] [Related]
4. [
Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
[TBL] [Abstract][Full Text] [Related]
5. Role of FDG-PET in the assessment of survival prognosis in melanoma.
Pleiss C; Risse JH; Biersack HJ; Bender H
Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
[TBL] [Abstract][Full Text] [Related]
6.
Wang Y; Li M; Zhang X; Ji H; Wang W; Han N; Li H; Xu X; Lan X
Mol Pharm; 2023 Jan; 20(1):572-581. PubMed ID: 36382713
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
8. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
Pyo A; Kim DY; Kim H; Lim D; Kwon SY; Kang SR; Kim HS; Bom HS; Min JJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12991-12999. PubMed ID: 32439710
[TBL] [Abstract][Full Text] [Related]
9. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
[TBL] [Abstract][Full Text] [Related]
11. Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.
Guo H; Shenoy N; Gershman BM; Yang J; Sklar LA; Miao Y
Nucl Med Biol; 2009 Apr; 36(3):267-76. PubMed ID: 19324272
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the biodistribution and PET imaging with (11)C-PDT and (18)F-FDG in the mouse model of lung adenocarcinoma].
Zhang T; Zhou NK; Zhang JM; Liang CY; Liu X; Tian XD
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):103-6. PubMed ID: 20403239
[TBL] [Abstract][Full Text] [Related]
13. Melanin-targeted preclinical PET imaging of melanoma metastasis.
Ren G; Miao Z; Liu H; Jiang L; Limpa-Amara N; Mahmood A; Gambhir SS; Cheng Z
J Nucl Med; 2009 Oct; 50(10):1692-9. PubMed ID: 19759116
[TBL] [Abstract][Full Text] [Related]
14. The Use of PET Imaging for Prognostic Integrin α
Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
16. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
17. Dynamic
Lockau H; Neuschmelting V; Ogirala A; Vilaseca A; Grimm J
J Nucl Med; 2018 Feb; 59(2):210-215. PubMed ID: 28912145
[TBL] [Abstract][Full Text] [Related]
18. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
19. High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
Denoyer D; Greguric I; Roselt P; Neels OC; Aide N; Taylor SR; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2010 Mar; 51(3):441-7. PubMed ID: 20150254
[TBL] [Abstract][Full Text] [Related]
20. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Shigemoto Y; Suga K; Matsunaga N
Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]